These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26064279)

  • 41. Interleukin-18 -137 G/C and -607 C/A polymorphisms and Alzheimer's disease risk: a meta-analysis.
    Zhang J; Song T; Liang H; Lian J; Zhang G; Gong H
    Neurol Sci; 2016 Jun; 37(6):921-7. PubMed ID: 26897018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders.
    Ozdemirkiran FG; Nalbantoglu S; Gokgoz Z; Payzin BK; Vural F; Cagirgan S; Berdeli A
    Arch Med Sci; 2017 Mar; 13(2):426-432. PubMed ID: 28261298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
    Xu B; Zhu Y; Tang Y; Zhang Z; Wen Q
    Med Sci Monit; 2018 Oct; 24():7057-7071. PubMed ID: 30286050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association between DVWA polymorphisms and osteoarthritis susceptibility: a genetic meta-analysis.
    Wang D; Zhou K; Chen Z; Yang F; Zhang C; Zhou Z; Pei F
    Int J Clin Exp Med; 2015; 8(8):12566-74. PubMed ID: 26550167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
    Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
    Yang M; Zou Y; Bai Y; Li M
    J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in the intercellular adhesion molecule 1 gene and cancer risk: a meta-analysis.
    Tang W; Wang Y; Chen Y; Gu H; Chen S; Kang M
    Int J Clin Exp Med; 2015; 8(8):11996-2008. PubMed ID: 26550112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between KIR polymorphisms and ankylosing spondylitis in populations: a meta-analysis.
    Fan D; Liu S; Yang T; Wu S; Wang S; Li G; Zeng Z; Duan Z; Xia G; Ye D; Zou Y; Xu S; Xu J; Zhang L; Shuai Z; Pan F
    Mod Rheumatol; 2014 Nov; 24(6):985-91. PubMed ID: 24673577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
    Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
    In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
    Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
    Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association analysis of
    Asgari R; Yari K; Mansouri K; Bakhtiari M
    Biomed Rep; 2018 Apr; 8(4):391-395. PubMed ID: 29541461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
    Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
    Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between the CD28 IVS3 +17T>C (rs3116496) polymorphism and cancer susceptibility: a meta-analysis involving 8,843 subjects.
    Zhang S; Wang Y; Jiang H; Liu C; Gu H; Chen S; Kang M; Tang W
    Int J Clin Exp Med; 2015; 8(10):17353-61. PubMed ID: 26770327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carriage of NBN polymorphisms and acute leukemia risk.
    Wang Y; Sun Z; Xu Y
    Int J Clin Exp Med; 2015; 8(3):3769-76. PubMed ID: 26064273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FAS-670 gene polymorphism and cervical carcinogenesis risk: A meta-analysis.
    Huang Q; Wang J; Hu Y
    Biomed Rep; 2013 Nov; 1(6):889-894. PubMed ID: 24649048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review.
    Timofeeva SV; Sherchkova TA; Shkurat TP
    Noncoding RNA; 2022 Nov; 8(6):. PubMed ID: 36412913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Author Correction: Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
    Sargazi S; Zahedi Abghari A; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
    Appl Biochem Biotechnol; 2022 Feb; 194(2):1025. PubMed ID: 34529231
    [No Abstract]   [Full Text] [Related]  

  • 60. Susceptibility to childhood leukemia.
    Feuchtinger T
    Blood; 2011 Aug; 118(5):1189-90. PubMed ID: 21816837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.